Aragen Life Sciences Acquires INTOX Pvt. Ltd.

Labcorp Acquires Toxikon Corporation

November 18, 2021

Healthcare Services

Labcorp has acquired Toxikon Corporation, a Bedford, Massachusetts-based contract research organization that provides nonclinical in vivo and in vitro testing for pharmaceutical, biotech and medical device clients. The acquisition expands Labcorp Drug Development's nonclinical testing capabilities and creates a strategic Boston-area footprint; Toxikon reported approximately $40 million in annual revenue and the deal closed in December 2021.

Scantox Group Acquires Gentronix Ltd

September 9, 2024

Healthcare Services

Scantox Group, together with its majority owner Impilo, has acquired Gentronix Ltd, a UK-based GLP-compliant genetic toxicology CRO headquartered at Alderley Park. The acquisition expands Scantox's preclinical service platform by adding specialist genetic, skin and ocular toxicology capabilities, bringing the Scantox Group to more than 400 employees across seven European sites.

APNAR Pharma Acquires Aurex Laboratories

February 3, 2022

Pharmaceuticals

APNAR Pharma LP, a privately owned pharmaceutical company based in Chino, California, has acquired East Windsor, New Jersey–based Aurex Laboratories. The deal adds US FDA–approved finished dosage manufacturing capabilities to APNAR’s platform, expanding its U.S. footprint, pipeline capacity and contract manufacturing capabilities to support APNAR’s ANDAs and third‑party partners.

ToxStrategies Acquires Clintrex Research Corporation

June 25, 2024

Healthcare Services

ToxStrategies, a Renovus Capital Partners–backed scientific consulting firm based in Katy, Texas, has acquired Clintrex Research Corporation, a Sarasota-based clinical and regulatory development services provider focused on neurodegenerative and CNS therapies. The deal (terms undisclosed) expands ToxStrategies' clinical, regulatory, biostatistics and drug‑development capabilities and is intended to broaden its end‑market reach in the life sciences sector.

Enhesa Acquires ToxPlanet

July 5, 2022

Data & Analytics

Enhesa has acquired ToxPlanet, adding the world's largest chemical hazard and toxicology literature database to its regulatory and sustainability intelligence offerings. The deal expands Enhesa's sustainable chemistry and product compliance capabilities, integrating ToxPlanet's content-as-a-service database into Enhesa's global compliance platform.

QIAGEN Acquires Genoox

May 12, 2025

Biotechnology

QIAGEN has signed a definitive agreement to acquire Genoox, the developer of the AI-powered Franklin clinical genomics platform, for $70 million in cash plus up to $10 million in milestone payments. The acquisition adds Genoox's cloud-based AI interpretation capabilities to QIAGEN Digital Insights, expanding QIAGEN's clinical genomics and diagnostic software offerings for labs and healthcare organizations worldwide.